| Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts S Baroni, S Romero-Cordoba, I Plantamura, M Dugo, E D’ippolito, ... Cell death & disease 7 (7), e2312-e2312, 2016 | 290 | 2016 |
| Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma V Huber, V Vallacchi, V Fleming, X Hu, A Cova, M Dugo, E Shahaj, ... The Journal of clinical investigation 128 (12), 5505-5516, 2018 | 233 | 2018 |
| Bioinformatics tools for secretome analysis D Caccia, M Dugo, M Callari, I Bongarzone Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1834 (11), 2442-2453, 2013 | 125 | 2013 |
| Perfusion of isolated rat kidney with Mesenchymal Stromal Cells/Extracellular Vesicles prevents ischaemic injury M Gregorini, V Corradetti, EF Pattonieri, C Rocca, S Milanesi, A Peloso, ... Journal of Cellular and Molecular Medicine 21 (12), 3381-3393, 2017 | 116 | 2017 |
| miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma E Minna, P Romeo, L De Cecco, M Dugo, G Cassinelli, S Pilotti, ... Oncotarget 5 (9), 2513, 2014 | 116 | 2014 |
| Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b E Vergani, L Di Guardo, M Dugo, S Rigoletto, G Tragni, R Ruggeri, ... Oncotarget 7 (4), 4428, 2016 | 104 | 2016 |
| miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis R El Bezawy, D Cominetti, N Fenderico, V Zuco, GL Beretta, M Dugo, ... Cancer letters 395, 53-62, 2017 | 94 | 2017 |
| miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma E Minna, P Romeo, M Dugo, L De Cecco, K Todoerti, S Pilotti, F Perrone, ... Oncotarget 7 (11), 12731, 2016 | 94 | 2016 |
| Metabolic footprints and molecular subtypes in breast cancer V Cappelletti, E Iorio, P Miodini, M Silvestri, M Dugo, MG Daidone Disease markers 2017 (1), 7687851, 2017 | 83 | 2017 |
| Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissues M Callari, M Dugo, V Musella, E Marchesi, G Chiorino, MM Grand, ... Public Library of Science 7 (9), e45105, 2012 | 74 | 2012 |
| Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients P Romeo, C Colombo, R Granata, G Calareso, AV Gualeni, M Dugo, ... Endocrine-related cancer 25 (3), 217-231, 2018 | 60 | 2018 |
| Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma B Ziccheddu, G Biancon, F Bagnoli, C De Philippis, F Maura, EH Rustad, ... Blood advances 4 (5), 830-844, 2020 | 57 | 2020 |
| A melanoma subtype with intrinsic resistance to BRAF inhibition identified by receptor tyrosine kinases gene-driven classification M Dugo, G Nicolini, G Tragni, I Bersani, A Tomassetti, V Colonna, ... Oncotarget 6 (7), 5118, 2015 | 51 | 2015 |
| miR-30e* is an independent subtype-specific prognostic marker in breast cancer F D'aiuto, M Callari, M Dugo, G Merlino, V Musella, P Miodini, B Paolini, ... British journal of cancer 113 (2), 290-298, 2015 | 49 | 2015 |
| LEADeR role of miR-205 host gene as long noncoding RNA in prostate basal cell differentiation V Profumo, B Forte, S Percio, F Rotundo, V Doldi, E Ferrari, N Fenderico, ... Nature communications 10 (1), 307, 2019 | 47 | 2019 |
| Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer L Castagnoli, GC Ghedini, A Koschorke, T Triulzi, M Dugo, P Gasparini, ... Oncogene 36 (12), 1721-1732, 2017 | 45 | 2017 |
| Infiltrating mast cell–mediated stimulation of estrogen receptor activity in breast cancer cells promotes the luminal phenotype MT Majorini, V Cancila, A Rigoni, L Botti, M Dugo, T Triulzi, L De Cecco, ... Cancer research 80 (11), 2311-2324, 2020 | 44 | 2020 |
| Gene expression signature of non-involved lung tissue associated with survival in lung adenocarcinoma patients A Galvan, E Frullanti, M Anderlini, G Manenti, S Noci, M Dugo, F Ambrogi, ... Carcinogenesis 34 (12), 2767-2773, 2013 | 44 | 2013 |
| Subtype-dependent prognostic relevance of an interferon-induced pathway metagene in node-negative breast cancer M Callari, V Musella, E Di Buduo, M Sensi, P Miodini, M Dugo, R Orlandi, ... Molecular oncology 8 (7), 1278-1289, 2014 | 42 | 2014 |
| Spatial predictors of immunotherapy response in triple-negative breast cancer XQ Wang, E Danenberg, CS Huang, D Egle, M Callari, B Bermejo, ... Nature 621 (7980), 868-876, 2023 | 41 | 2023 |
